Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | GLA | P06280 | 1/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.61 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.60 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.58 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | AR | P10275 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.57 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.56 |
| ▸ | TUBB | P07437 | 1/20 | 0.56 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.56 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.56 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9281549 | 0.91 | TAAR1 (0.76) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL1485966 | 0.88 | TAAR1 (0.71) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL5072123 | 0.88 | TAAR1 (0.76) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL19545805 | 0.86 | TAAR1 (0.69) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL10683411 | 0.86 | ALOX15 (0.70) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL6566912 | 0.85 | HTR1A (0.69) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL3158703 | 0.85 | TAAR1 (0.67) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL7186374 | 0.84 | ATM (0.59) | ALDH1A1CYP3A4TUBB4ATUBBTUBA3C | |
| SCHEMBL29604390 | 0.84 | PTPN1 (0.82) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL17780116 | 0.84 | PTPN1 (0.82) | TAAR1TSHRMAPK1LMNAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11123272-B2 | Cosmetic blends | SYMRISE AG (DE) | 2021-09-21 | — | — | US | claimed |
| CN-110025496-A | A kind of sorbefacient skin care item and preparation method thereof | 烟台哈美医疗科技有限公司 | 2019-07-19 | — | — | CN | claimed |
| CN-109646379-A | A kind of thermal sensation plant footbath liquor and preparation method thereof | 广东暨晴生物医药科技有限公司 | 2019-04-19 | — | — | CN | claimed |
| CN-108078842-A | A kind of proton pump kudzu root nutrient Essence and its preparation method and application | 陈芳芳 | 2018-05-29 | — | — | CN | claimed |
| US-20160206553-A1 | COLD-WARM PLASTER | ALTERGON S.A. (CH) | 2016-07-21 | — | — | US | claimed |
| US-20240130957-A1 | EXTRACTS OF ISOCHRYSIS SPECIES/TISOCHRYSIS SPECIES | SYMRISE AG (DE) | 2024-04-25 | — | — | US | disclosed |
| US-11622920-B2 | Delivery system for active agents | SYMRISE AG (DE) | 2023-04-11 | — | — | US | disclosed |
| CN-114796375-A | Pain-relieving and collateral-activating oil for rheumatism | 金中北 | 2022-07-29 | — | — | CN | disclosed |
| CN-114522118-A | Foaming type facial cleanser with warming effect and preparation method thereof | 诺斯贝尔化妆品股份有限公司 | 2022-05-24 | — | — | CN | disclosed |
| EP-3730124-A1 | SOLID COSMETIC | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2020-10-28 | — | — | EP | disclosed |
| CN-110269926-A | Middle benefit gas, which is relaxed, warms up composition and its preparation method and application | 深圳市容大生物技术有限公司 | 2019-09-24 | — | — | CN | disclosed |
| CN-110168038-A | Methyl menthol derivative and cold feeling agent composition containing it | 高砂香料工业株式会社 | 2019-08-23 | — | — | CN | disclosed |
| US-20060269500-A1 | Topical warming composition | TAKASAGO INTERNATIONAL CORP. (USA) (US) | 2006-11-30 | — | — | US | disclosed |
| CN-1805728-A | Shampoo and body detergent composition | TAKASAGO PERFUMERY CO LTD (JP) | 2006-07-19 | — | — | CN | disclosed |
| EP-1649759-A1 | FLAVOR ENHANCER, FOOD OR BEVERAGE CONTAINING THE FLAVOR ENHANCER, AND METHOD OF FLAVOR ENHANCEMENT | Takasago International Corporation (JP) | 2006-04-26 | — | — | EP | disclosed |
| CN-1758896-A | Composition comprising zinc-containing layered material having relatively high zinc lability | PROCTER & GAMBLE (US) | 2006-04-12 | — | — | CN | disclosed |
| CN-1758895-A | Use of zinc-containing layered materials to increase pyrithione activity or polyvalent metal salt activity of pyrithione | PROCTER & GAMBLE (US) | 2006-04-12 | — | — | CN | disclosed |
| CN-1758893-A | Composition comprising particulate zinc material having defined crystallite size | PROCTER & GAMBLE (US) | 2006-04-12 | — | — | CN | disclosed |
| CN-1646124-A | Use of substances with zinc ionophore properties | PROCTER & GAMBLE ARCH CHEMICAL (US) | 2005-07-27 | — | — | CN | disclosed |
| US-6570010-B2 | Comprises a cyclodextrin or a branched cyclodextrin and a vanillyl alcohol derivative, such as vanillyl-n butyl ether | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11123272-B2 | Cosmetic blends | TRPA1, TRPV3, TRPV1 | TAAR1 182/4885TSHR 3909/4885MAPK1 2903/4885 |
| US-20060269500-A1 | Topical warming composition | CUTA, NACA, LSM14A | TAAR1 3783/4885TSHR 3612/4885MAPK1 4221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.